---
title: The horrible convoluted statistical procedures that are used to make decisions
  about something as important as Alzheimer’s treatments
date: '2021-08-23'
linkTitle: https://statmodeling.stat.columbia.edu/2021/08/23/the-horrible-convoluted-statistical-procedures-that-are-used-to-make-decisions-about-something-as-important-as-alzheimers-treatments/
source: Statistical Modeling, Causal Inference, and Social Science
description: 'Richard Juster points to this article, &#8220;Evaluation of Aducanumab
  for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy,
  Safety, and Futility.&#8221; The article begins: On November 6, 2020, a US Food
  and Drug Administration (FDA) advisory committee reviewed issues related to the
  efficacy and safety of aducanumab, a human IgG1 anti-Aβ monoclonal antibody specific
  ...'
disable_comments: true
---
Richard Juster points to this article, &#8220;Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility.&#8221; The article begins: On November 6, 2020, a US Food and Drug Administration (FDA) advisory committee reviewed issues related to the efficacy and safety of aducanumab, a human IgG1 anti-Aβ monoclonal antibody specific ...